Health care biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 health care biotech companies ranked by P/S ratio, at 3.7, followed by Qiagen (4.9) and Neurocrine Biosciences (5.5). Figures as of 20 Nov 2026, 04:16 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.7
Median
14.3
Combined market value
SGD 1.07T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
Health Care
Biotech
SGD
Clear filters
Health care biotech companies by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.7SGD 47.1BSGD 318.87 1.70% down 49% up United States
2QiagenQGEN · Health Care4.9SGD 13.2BSGD 64.04 0.14% up 9% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.5SGD 20.5BSGD 202.04 3.85% down 17% up United States
4BioNTechBNTX · Health Care6.3SGD 26BSGD 105.00 2.26% down 14% down Germany
5AmgenAMGN · Health Care6.5SGD 306.3BSGD 566.20 1.14% down 32% up United States
6ExelixisEXEL · Health Care6.9SGD 20.7BSGD 84.94 3.60% down 63% up United States
7Gilead SciencesGILD · Health Care7.0SGD 266.5BSGD 214.87 1.45% down 35% up United States
8Halozyme TherapeuticsHALO · Health Care7.6SGD 13.7BSGD 120.05 2.88% down 39% up United States
9Bio-TechneTECH · Health Care9.4SGD 14.7BSGD 93.80 0.07% down 24% up United States
10argenxARGX · Health Care14.3SGD 76.4BSGD 1,215.50 0.08% up 2% up Belgium
11RepligenRGEN · Health Care14.7SGD 14BSGD 219.72 1.38% down 12% up United States
12Adaptive BiotechnologiesADPT · Health Care16.4SGD 5.9BSGD 36.19 1.44% down 74% up United States
13Twist BioscienceTWST · Health Care20.2SGD 9.8BSGD 144.02 4.07% down 346% up United States
14Krystal BiotechKRYS · Health Care24.1SGD 12.1BSGD 407.50 0.15% up 54% up United States
15ModernaMRNA · Health Care41.5SGD 104.1BSGD 257.19 1.29% up 780% up United States
16ImmunityBioIBRX · Health Care61.7SGD 9BSGD 8.48 1.94% down 232% up United States
17Kymera TherapeuticsKYMR · Health Care260SGD 13.2BSGD 154.05 1.44% down 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1076SGD 4.9BSGD 50.23 3.14% down 18% down Switzerland
19CG OncologyCGON · Health Care1811SGD 9.4BSGD 105.67 2.38% up 97% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2903 SGD). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which health care biotech companies have the lowest P/S ratio?

Biogen (3.7), Qiagen (4.9) and Neurocrine Biosciences (5.5) have the lowest P/S ratio of the 19 health care biotech companies ranked here as of 20 Nov 2026, 04:16 UTC.

How many health care biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these health care biotech companies worth together?

The 19 health care biotech companies ranked by P/S ratio have a combined market value of SGD 1.07T as of 20 Nov 2026, 04:16 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Health care biotech companies by P/S ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.